Mental retardation is associated with plasma omega-3 fatty acid levels and the omega-3/omega-6 ratio in children;Chinese Source

Asia Pacific Journal of Clinical Nutrition

Volumn 18, Issue 1, 2009, Pages 22-28

  Neggers, Yasmin H ^a   Kim, Eun Kyung ^b   Song, Ju Mi ^b   Chung, Eun Jung ^c   Um, Young Sook ^d   Park, Taesun ^d  

^a THE UNIVERSITY OF ALABAMA   (United States)

^b Gangneung Wonju National University   (South Korea)

^c Kangnam University   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Children; Docosahexanoic acid; Mental retardation; Omega 3 fatty acids; Plasma omega 6 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID;

ARTICLE; BLOOD; CALORIC INTAKE; CASE CONTROL STUDY; CHILD; FAT INTAKE; HUMAN; MALE; MENTAL DEFICIENCY; RISK FACTOR;

CASE-CONTROL STUDIES; CHILD; CHOLESTEROL, HDL; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; ENERGY INTAKE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; MALE; MENTAL RETARDATION; PHOSPHOLIPIDS; RISK FACTORS;

EID: 67649921032     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR. Essential fatty acid metabolism in boys with attention deficit hyperactivity disorder. Am J Clin Nutr. 1995;62:761-8.
2. Horrobin DF, Bennett CN. Phospholipid metabolism and the pathophysiology of psychiatric disorders. In: Peet M, Glen AIM, Horrobin GF editors. Phospholipid Spectrum Disorders in Psychiatry and Neurology. Carnforth, UK: Marius press; 2003. p.3-48.
3. Kapoor R, Huang YS. Gamma linolenic acid: an anti-inflammatory omega-6 fatty acid. Curr Pharm Biotechnol. 2006:7:531-4.
4. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000;19:1784-93.
5. Scaglioni S, Veduci E, Agostoni C, Vergani B, Stival G, Riva E, Giovannini M. Dietary habits and plasma fatty acids levels in a population of Italian children: is there any relationship? Prostaglandins Leukot Essent Fatty Acids. 2004; 71:91-5.
6. Young GS, Conquer JA, Thomas R. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev. 2005;45: 549-58.
7. Young G, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev. 2005;45:1-28.
8. Conklin SM, Manuck SB, Yao JK, Flory JD, Hibbeln JR, Muldoon MF. High omega-6 and low omeg-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med. 2007;69(9):932-4.
9. Hoyos C, Almqvist C, Garden F. Xuan W, Oddy W, Marks GB, Webb KL. Effect of omega 3 and omega 6 fatty acid intakes from diet and supplements on plasma fatty acid levels in the first 3 years of life. Asia Pac J Clin Nutr. 2008;17: 552-7.
10. Vancassel S, Durand G, Barthelemy C, Lejeune B, Martineau J, Guilloteau D, Andres C, Chalon S. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids. 2001;65:1-7.
11. Richardson AJ, Ross MA. Fatty acid metabolism in neurodevelopment disorder; a new perspective on associations between attention deficit/hyperactivity disorder, dyslexia, dyspraxia and autistic spectrum. Prostaglandins Leukot Essent Fatty Acids. 2000;63:1-9.
12. Burgess JR, Stevens L, Zhang W, Peck L. Long chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr. 2000;71(Suppl):S327-30.
13. Sliwinski S, Croonenberghs J, Christophe A, Deboutte D, Maes M. Polyunsaturated fatty acids: do they have a role in pathophysiology of autism? Neuro Endocrinol Lett. 2006; 27(4):465-71.
14. Bell JG, Mackinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen ACA. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids. 2004;71:201-4.
15. Croen LA, Grether JK, Slevin S. The epidemiology of mental retardation of unknown causes. Pediatrics. 2001;107(6): e-86.1410.
16. Murphy CC, Boyle C, Schendel D, Decoufle P, Yeargin-Allsopp M. Epidemiology of mental retardation in children. Mental Retard Dev Disab Rev.1998;4:6-13.
17. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, 4th edition, DSM IV. Washington, DC: American Psychiatric Press; 1994.
18. Folch J, Less M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
19. Lepage G, Roy GC. Direct trans-esterification of all classes of lipids in a one step reaction. J lipid Res. 1986; 7:114-29.
20. Fridwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
21. Korean Society of Nutrition. Computer Aided Nutritional Analysis Program (CAN-Pro, version 2.0) 2005.
22. Colter AL, Cutler C, Meckling KA. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case control study. Nutr J. 2008;7:8-15.
23. Noori M, Darabi M, Rahimipour A, Rahbani M, Abadi NA, Darabi M, Ghatrehsamani K. Fatty acid composition of HDL phospholipids and coronary artery disease. J Clin Lipidology. 2009;3:39-44.
24. Hodges AM, Simpson JA, Gibson RA, Sinclair AJ, Makides M, O. Dea K, English DR, Giles GG. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metabolism Cardiovascular Dis. 2007;17:415-26.
25. Innis S.M. Dietary (n-3) fatty acids and brain development. J. Nutr. 2007;137:855-9.
26. Polozova A, Gionfriddo E, Salem N. Effect of docosahexaenoic acid on tissue targeting and metabolism of plasma lipoproteins. Prostaglandins Leukot Essent Fatty Acids. 2006;75:183-90.
27. Lefkowitz SY, Lim YH, Salem N. Where does the developing brain obtain its docosahexaenoic acid? Relative contributions of dietary alpha-linolenic acid, docosahexaenoic acid and body stores in the developing rat. Pediatr Res. 2005;57;157-65.
28. Horrobin DF. The membrane phospholipids hypothesis as a biochemical basis for the neurodevelopment concept of schizophrenia. Schizophr Res. 1998;30:193-208.
29. Horrobin DF, Bennett CN. New gene targets related schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids. 1999;60:141-67.